Story · Medicine & Biotech · Nutrition

Psilocybin, cognitive stability and drinking reduction in co-occurring alcohol use disorder and depression: a pilot secondary analysis of a randomized, placebo-controlled trial

1 outlet · first reported by medRxiv (all subjects) 14d ago

Coverage, in order

  1. 14d ago
    medRxiv (all subjects) obscure study randomized trial
    Psilocybin, cognitive stability and drinking reduction in co-occurring alcohol use disorder and depression: a pilot secondary analysis of a randomized, placebo-controlled trial

    Background. Change in cognitive control is a candidate transdiagnostic mechanism of psychedelic therapy. One account predicts that, once acute effects resolve, psilocybin shifts control toward flexibility while sparing inhibition and working memory. A motivational account (PRISM) predicts that…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.